Structure‐Function Relationships of Heparan Sulfate‐Based Neoproteoglycans as Selective Immunostimulatory Scaffolds
Chemistry – A European Journal · 04.12.2025 · 31 (68)
DOI: 10.1002/chem.202502735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 30.10.2025. Verfasst von Ankita Chandra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, India. Hauptthemen laut MEDLINE: Heparan Sulfate, Adjuvants, Immunologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Mission on Nano Science and Technology, DBT, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Heparan sulfate proteoglycans (HSPGs) play a critical role in regulating inflammatory responses. Their diverse functions arise from the distinct structural heterogeneity of heparan sulfate (HS) side chains. Deciphering these structural determinants offers a promising strategy for developing novel vaccine adjuvants and immunotherapeutic agents. Herein, we evaluated a panel of neoproteoglycans (neoPGs) functionalized with structurally defined HS oligosaccharides to identify ligands that selectively trigger cytokine responses in immune cells. Our results demonstrate that highly sulfated, L‐iduronic acid‐containing, N ‐sulfated HS‐conjugated neoPGs, specifically H7 and H12 induced pro‐inflammatory cytokines TNF‐α, IL‐1β, and IL‐6 in human peripheral blood mononuclear cells (PBMCs), compared to their D‐glucuronic acid analogs. Notably, cotreatment with lipopolysaccharide (LPS) did not result in a synergistic increase in cytokine levels, indicating that these HS neoPGs likely activate immune signaling independently of the LPS‐mediated pathway. In contrast, similar experiments with murine macrophage cell line PMJ2‐PC showed only modest cytokine induction, particularly with the H6 ligand, further supporting a cell‐type specific and Toll‐like receptor (TLR) independent mechanism of action. Collectively, these data identify structurally distinct HS domains that can function as cell‐specific immunomodulators, offering new opportunities for the rational design of glycan‐based adjuvants and therapeutic immune regulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, India.
- Department of Medical Biochemistry and Microbiology, The Biomedical Center, Uppsala University, Uppsala, 75123, Sweden.
- Department of CPAS, Jackson State University, Jackson, MS, 39217, USA.
ORCID-Profile: Raghavendra Kikkeri
Förderung
- Mission on Nano Science and Technology
- DBT
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Chandra, A., Maccarana, M., Vishweshwara, S. S., Mardhekar, S., Anand, S., Bhoge, P. R., Li, J. P., & Kikkeri, R. (2025). Structure‐Function Relationships of Heparan Sulfate‐Based Neoproteoglycans as Selective Immunostimulatory Scaffolds. Chemistry – A European Journal, 31(68). https://doi.org/10.1002/chem.202502735
Vancouver
Chandra A, Maccarana M, Vishweshwara SS, Mardhekar S, Anand S, Bhoge PR, et al. Structure‐Function Relationships of Heparan Sulfate‐Based Neoproteoglycans as Selective Immunostimulatory Scaffolds. Chemistry – A European Journal. 2025;31(68). doi:10.1002/chem.202502735
BibTeX
@article{Chandra2025,
author = {Chandra, Ankita and Maccarana, Marco and Vishweshwara, Sharath S and Mardhekar, Sandhya and Anand, Saurabh and Bhoge, Preeti Ravindra and Li, Jin-Ping and Kikkeri, Raghavendra},
title = {Structure‐Function Relationships of Heparan Sulfate‐Based Neoproteoglycans as Selective Immunostimulatory Scaffolds},
journal = {Chemistry – A European Journal},
year = {2025},
volume = {31},
number = {68},
doi = {10.1002/chem.202502735}
}
EUVIMED